Visit us & discover the BEST brain molecular imaging for everyone at our booth #2127
MINDVIEW is the new business unit of Oncovision for personalized molecular brain imaging and care. Its first product, CAREMIBRAIN, ULTRA-HIGH RESOLUTION dedicated brain PET, perfected since 2017, has proven clinical outcomes in >600 PATIENTS at leading hospitals in Spain, Germany and the United States, and FDA APPROVAL (since 2023).
ADVANCED, ACCESSIBLE and AFFORDABLE, Caremibrain is combining ultra-high resolution 1,5 mm, 10% sensitivity, powerful quantification / dynamic capabilities, award-winning patient experience, vastly reduced radiotracer dose and very short study time.
Compact, light, energy-efficient, CMB is enabling access to the BEST brain PET that every person deserves, with unequalled productivity, ease of use, seamless multimodal integration, minimum initial / ongoing costs and turnkey options. Unprecedented screening, clinical diagnosis, therapy guidance, treatment results assessment, advanced neurological research and synergy imaging / tracer / therapy opportunities for EVERYONE, EVERYWHERE..
Brands: CareMiBrain an ULTRA-HIGH RESOLUTION dedicated brain PET with extensive technical and clinical assessment and proven clinical outcomes in MORE THAN 600 PATIENTS at leading hospitals in Spain, Germany and US (FDA approval).